Psychedelic Medicine's Future Depends on Proactive Development of a Robust Medical Billing and Coding Strategy.
Psychedelic medicine (New Rochelle, N.Y.) March 1, 2023 Brian S. Barnett, Andrey Ostrovsky 6 citations
Although still investigational, psychedelic therapies appear poised to begin securing regulatory approval as medical treatments in the United States within the next 2 years. If approved, one of the most daunting barriers to equitable patient access to these novel treatments is their incorporation into the medical billing and coding system. Since specific billing codes for psychedelic therapy...